Have a personal or library account? Click to login
Review: complement receptor 1 therapeutics for prevention of immune hemolysis Cover

Review: complement receptor 1 therapeutics for prevention of immune hemolysis

Immunohematology
Volume 21 (2005): Issue 3 (September 2005)
By: K. Yazdanbakhsh  
Paid access
|Apr 2020

Authors

K. Yazdanbakhsh

Complement Biology, New York Blood Center, New York, United States
DOI: https://doi.org/10.21307/immunohematology-2019-402 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 109 - 118
Published on: Apr 27, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
complement,
complement receptor 1,
sCR1,
inhibitors,
LHR,
immune hemolysis,
autoimmune hemolytic anemia,
transfusion medicine,
regulatory T cells,
CD4+CD25+
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2020 K. Yazdanbakhsh, published by American National Red Cross
This work is licensed under the Creative Commons License.

Previous articleVolume 21 (2005): Issue 3 (September 2005)Next article